Professor Dr. Robert Schiestl Ph. D. Joins Pacific Software Inc. as Chief Science Advisor (CSA)

Written by Customer Service on . Posted in Public Companies.

DANA POINT, Calif., July 22, 2024 (GLOBE NEWSWIRE) — Pacific Software Inc.(OTC:PFSF), an emerging skincare, and aesthetics company known for its patented cosmeceutical technology Dermatrix and science-based dietary supplements, is excited to announce the appointment of Professor Dr. Robert Schiestl Ph.D. as its Chief Science Advisor (CSA), effective immediately.

Dr. Robert Schiestl is a distinguished scientist who received his Ph.D. from the University of Vienna, Austria with an extensive background in molecular toxicology, cancer prevention, and genomics. He was previously Assistant and Associate Professor in the Department of Cancer Research and later Toxicology at the Harvard School of Public Health. He is currently Professor Emeritus of Pathology, Environmental Health Sciences and Radiation Oncology at UCLA. He was a Director of the UCLA Center for Environmental Genomics, member of the UCLA Cancer Center and Occupational and Environmental Health Sciences. He was also a member of the Interdepartmental Program in molecular Toxicology (advisory committee) at UCLA. Dr. Schiestl has authored over 200 peer-reviewed publications and has been recognized with numerous awards for his groundbreaking research and contributions to science.

Dr. Schiestl’s work focuses on the mechanisms of genetic stability and the development of strategies to prevent genetic diseases and cancer. His research has provided significant insights into the field of oxidative stress and its impact on health, which aligns perfectly with the company’s mission to develop innovative skincare products and science-based dietary supplements.

Dr. Schiestl’s Achievements and Contributions Include:

  • Over 200 peer-reviewed publications in prestigious scientific journals, 9 press releases and 16 patents and 6 companies.
  • Recipient of numerous awards including Outstanding Leadership Award in Healthcare 2022, Outstanding Visionary Award in Healthcare 2023, Outstanding Organization Award in Healthcare 2024, Outstanding Education Award 2023, The Outstanding MORE Leadership Award (Money and Real Estate) in 2023, Outstanding CXO Award 2024 as best CEO, the Outstanding Leadership Award in Internet 2024, The Best Speakership Award at The International Conference on Nursery, Patient Safety and Healthcare 2023.
  • Pioneering research in genetic stability and cancer prevention and Health.
  • Development of novel strategies to combat oxidative stress-related health issues.

Harrysen Mittler, CEO stated: “We are thrilled to welcome Dr. Robert Schiestl to our team as our Chief Science Advisor. His unparalleled expertise and visionary approach to scientific research will be invaluable as we continue to advance our cosmeceutical technology and dietary supplements to commercial status. His insights and guidance may play a crucial role in shaping the future of our innovations and supplement offerings.”

About Pacific Software Inc.

Pacific Software Inc. is an emerging cosmetics and aesthetics company developing skincare products featuring its patented cosmeceutical technology known as Dermatrix. Additionally, the company expects to produce science-based dietary supplements designed to promote overall health and wellness. Recently the company announced the acquisition of a science based dietary supplement supporting brain health and memory function. The supplement was sold over a period of 8 years under the brand names of SuppleMEM AD™ and A.L.Z. Defense™ featuring a formula tested extensively by leading Alzheimer’s researchers. The Company intends to resurrect these brand names and commercial product applications in the USA and Mexico.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words “may,” “will,” “should,” “plans,” “expects,” “anticipates,” “continue,” “estimates,” “projects,” “intends,” and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, PFSF’s ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners, and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various scientific and manufacturing programs, changes in future customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond PFSF’s control. Except as may be required by law, Pacific Software, Inc. undertakes no obligation, and does not intend, to update these forward-looking statements after the date of this release.

Contact:

Harrysen Mittler, CEO
Tel: (310) 600-5064
E-mail: info@pacificsoftwareinc.com
Website: pacificsoftwareinc.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.